Chris Hannay
LightNews LightNews
hannay.bsky.social
Chris Hannay
@hannay.bsky.social
5.1K followers 250 following 6 posts
Health and business reporter at The Globe and Mail
Posts Replies Media Videos
Reposted by Chris Hannay
theglobeandmail.com
U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries
Washington turning up pressure on manufacturers to lower U.S. drug prices and raise them elsewhere
www.theglobeandmail.com
November 11, 2025 at 12:00 AM
Reposted by Chris Hannay
theglobeandmail.com
Ontario to ban exclusivity deals between insurers, pharmacies
Move follows Globe reporting on closed preferred pharmacy networks that restrict where patients can buy medication
www.theglobeandmail.com
November 6, 2025 at 6:17 PM
Reposted by Chris Hannay
picardonhealth.bsky.social
Myeloma patients demand immunotherapy pricing talks resume. Carvykti was approved by Health Canada in 2023, but still unavailable to cancer patients due to lack of deal on price, by @kellygrant1.bsky.social @hannay.bsky.social www.theglobeandmail.com/canada/artic... via @theglobeandmail.com
Myeloma patients launch campaign for immunotherapy pricing talks to resume
Health Canada approved cutting-edge treatment nearly three years ago but it still isn’t available here
www.theglobeandmail.com
November 3, 2025 at 11:18 AM
Reposted by Chris Hannay
theglobeandmail.com
Canadians can wait years to get drugs regulators have already deemed safe. Why?
Even after treatments pass Health Canada’s review, getting them publicly reimbursed here takes longer than any other G7 country
www.theglobeandmail.com
October 31, 2025 at 9:08 AM
Reposted by Chris Hannay
theglobeandmail.com
Indian pharma giant says Health Canada rejected its application to make generic semaglutide
Decision is a setback for Dr. Reddy’s Laboratories, which was poised to be one of the first generic competitors to Ozempic
www.theglobeandmail.com
October 29, 2025 at 11:58 PM
Reposted by Chris Hannay
theglobeandmail.com
Drug maker Vimy Pharma plans to deliver made-in-Canada generic Ozempic
Ozempic and Wegovy lose market exclusivity in January, clearing the way for generic formulations of semaglutide
www.theglobeandmail.com
October 16, 2025 at 9:07 AM
Reposted by Chris Hannay
theglobeandmail.com
Ontario to offer early access to some new cancer drugs in pilot project
Meanwhile, national public insurance body vows to speed up price negotiations – possibly eliminating the need for the pilot project
www.theglobeandmail.com
October 7, 2025 at 9:02 AM
Reposted by Chris Hannay
theglobeandmail.com
Canadian virtual pharmacy PurposeMed expands Freddie HIV treatment to all 50 U.S. states
Freddie currently provides pre-exposure prophylaxis, or PrEP, to 13,500 patients
www.theglobeandmail.com
October 1, 2025 at 10:06 AM
Reposted by Chris Hannay
theglobeandmail.com
Health startup founded by Canadians expands AI-powered dementia treatment, raises more funding
Moneta Health announced Tuesday it had raised US$4.5-million from several investors including the Ontario Teachers’ Pension Plan and BKR Capital
www.theglobeandmail.com
September 23, 2025 at 10:08 AM
Reposted by Chris Hannay
theglobeandmail.com
Moderna to roll out first made-in-Canada COVID-19 vaccines this fall
Facilities in Laval, Que., and Cambridge, Ont. producing U.S. drugmaker’s mRNA vaccines
www.theglobeandmail.com
September 19, 2025 at 10:06 AM
Reposted by Chris Hannay
theglobeandmail.com
Novo Nordisk partners with Pocketpills for online sales of Ozempic, Wegovy
Pocketpills operates four fulfilment centres across Canada to deliver medications in all provinces except Quebec
www.theglobeandmail.com
September 18, 2025 at 11:12 AM
Reposted by Chris Hannay
theglobeandmail.com
Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissions
Number of biosimilar submissions increased more than 400% from 2016 to 2025, while departmental resources remained ‘relatively constant’
www.theglobeandmail.com
September 4, 2025 at 9:27 PM
Reposted by Chris Hannay
theglobeandmail.com
Manulife is steering Wegovy and Mounjaro patients to Shoppers pharmacies
The insurer has been directing patients to pharmacies owned by Loblaw, despite facing backlash for its preferred provider networks deals with the retailer
www.theglobeandmail.com
September 3, 2025 at 9:07 AM
Reposted by Chris Hannay
canadahealthwatch.ca
Untangling the Information Ecosystem — Health, Media, and the Public (Guests: @hannay.bsky.social & @nicktsergas.ca)
podcasts.apple.com/ca/podcast/u...
Untangling the Information Ecosystem - Health, Media, and the Public
Podcast Episode · Digital Health in Canada · 2025-08-25 · 41m
podcasts.apple.com
August 26, 2025 at 2:13 PM
Reposted by Chris Hannay
theglobeandmail.com
Specialty pharmacy chain SRx files for creditor protection after unsuccessful roll-up strategy
At the time of its application to the Ontario Superior Court of Justice on Aug. 12, SRx operated 17 specialty pharmacies and 19 clinics across Canada
www.theglobeandmail.com
August 26, 2025 at 10:07 AM
Reposted by Chris Hannay
theglobeandmail.com
How a new mental-health app is helping patients reality-check their hallucinations
A4i aims to help patients by providing coping strategies, documenting moods and preventing crises
www.theglobeandmail.com
August 21, 2025 at 10:07 AM
Reposted by Chris Hannay
theglobeandmail.com
Eli Lilly hikes weight-loss drug prices in Canada after pressure from Trump
Trump administration demands lower prices in the U.S., forcing the pharmaceutical company to raise them in other markets
www.theglobeandmail.com
August 14, 2025 at 5:42 PM
Reposted by Chris Hannay
theglobeandmail.com
Conservatives call for investigation of Spanish drugmakers’ use of Canadian-donated blood plasma
The Globe and Mail previously found that Canadian Blood Services is selling some blood components to Grifols
www.theglobeandmail.com
August 13, 2025 at 11:45 PM
Reposted by Chris Hannay
theglobeandmail.com
Spanish drugmaker using Canadian-donated blood plasma for products sold abroad
Canadian Blood Services had pledged that all blood donations would be used for products that stay in Canada
www.theglobeandmail.com
August 12, 2025 at 11:05 AM
Reposted by Chris Hannay
canadahealthwatch.ca
Speeding up drug approval timelines a priority, health minister says www.theglobeandmail.com/business/eco... @hannay.bsky.social

𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁
Minister of Health Marjorie Michel says one way to speed up drug approval timelines is earlier screening of applications.
August 7, 2025 at 6:33 AM
Reposted by Chris Hannay
theglobeandmail.com
Speeding up drug approval timelines a priority, health minister says
Liberals promised to ‘significantly reduce’ wait times for pharmaceuticals, which it acknowledged were longer than in other Group of Seven countries
www.theglobeandmail.com
August 6, 2025 at 7:14 PM
Reposted by Chris Hannay
theglobeandmail.com
Some Wegovy prescriptions redirected to pharmacies that signed exclusive deals with insurers
It’s the most high-profile example yet of a controversial industry practice called preferred pharmacy networks, or PPNs
www.theglobeandmail.com
August 6, 2025 at 9:02 AM
Reposted by Chris Hannay
theglobeandmail.com
Health Canada taking longer to approve generic drugs, data show
Delays in the approval process mean it takes longer for cheaper drugs to reach the market
www.theglobeandmail.com
August 5, 2025 at 9:06 AM
Reposted by Chris Hannay
theglobeandmail.com
Trump demands drug companies lower prices in U.S. and raise them in other countries
White House has issued letters to 17 pharma giants, giving them 60 days to take action
www.theglobeandmail.com
August 1, 2025 at 12:27 PM
Reposted by Chris Hannay
canadahealthwatch.ca
Potential U.S. tariffs, pricing rules raise uncertainty in drug industry www.theglobeandmail.com/business/art... @hannay.bsky.social

𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁
Only a small amount of pharmaceuticals consumed in the U.S. are fully produced there with a recent analysis showing 12 per cent of active ingredients made there.
July 11, 2025 at 6:11 AM